DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,446,028 | +4.3% | 54,196 | +0.9% | 0.66% | +10.2% |
| Q2 2023 | $12,894,960 | -5.0% | 53,729 | -0.2% | 0.60% | -12.4% |
| Q1 2023 | $13,574,623 | -6.1% | 53,859 | -1.1% | 0.68% | -9.3% |
| Q4 2022 | $14,454,243 | +1.2% | 54,458 | -1.5% | 0.75% | -4.5% |
| Q3 2022 | $14,284,000 | +1.3% | 55,304 | -0.6% | 0.78% | +7.1% |
| Q2 2022 | $14,100,000 | -13.1% | 55,618 | +0.5% | 0.73% | +5.5% |
| Q1 2022 | $16,233,000 | -11.0% | 55,339 | -0.2% | 0.70% | -5.2% |
| Q4 2021 | $18,240,000 | +5.9% | 55,437 | -2.0% | 0.73% | -0.3% |
| Q3 2021 | $17,222,000 | +12.1% | 56,572 | -1.2% | 0.74% | +15.6% |
| Q2 2021 | $15,365,000 | +20.5% | 57,256 | +1.1% | 0.64% | +10.4% |
| Q1 2021 | $12,749,000 | +0.8% | 56,641 | -0.5% | 0.58% | +0.3% |
| Q4 2020 | $12,651,000 | +3.7% | 56,953 | +0.5% | 0.57% | -5.7% |
| Q3 2020 | $12,204,000 | +18.7% | 56,677 | -2.5% | 0.61% | +8.4% |
| Q2 2020 | $10,279,000 | +30.9% | 58,132 | +2.5% | 0.56% | +9.8% |
| Q1 2020 | $7,851,000 | -4.0% | 56,727 | +6.4% | 0.51% | +24.3% |
| Q4 2019 | $8,180,000 | +5.0% | 53,293 | -1.2% | 0.41% | +0.2% |
| Q3 2019 | $7,790,000 | -0.9% | 53,934 | -1.9% | 0.41% | +0.7% |
| Q2 2019 | $7,861,000 | +8.2% | 55,004 | -0.1% | 0.41% | +4.3% |
| Q1 2019 | $7,268,000 | +50.9% | 55,054 | +17.9% | 0.39% | +91.7% |
| Q4 2018 | $4,815,000 | +10.4% | 46,693 | +16.3% | 0.20% | +30.8% |
| Q3 2018 | $4,363,000 | +1027.4% | 40,151 | +924.8% | 0.16% | +940.0% |
| Q2 2018 | $387,000 | +2.7% | 3,918 | +1.6% | 0.02% | +7.1% |
| Q1 2018 | $377,000 | +5.3% | 3,855 | 0.0% | 0.01% | +7.7% |
| Q4 2017 | $358,000 | +12.2% | 3,855 | +3.8% | 0.01% | +8.3% |
| Q3 2017 | $319,000 | +12.7% | 3,715 | +10.7% | 0.01% | +9.1% |
| Q2 2017 | $283,000 | -1.4% | 3,355 | +0.1% | 0.01% | -8.3% |
| Q1 2017 | $287,000 | -68.0% | 3,350 | -71.0% | 0.01% | -69.2% |
| Q4 2016 | $898,000 | +8.8% | 11,540 | +9.6% | 0.04% | +2.6% |
| Q3 2016 | $825,000 | -9.1% | 10,525 | +17.1% | 0.04% | -9.5% |
| Q2 2016 | $908,000 | +24.7% | 8,990 | +17.2% | 0.04% | +16.7% |
| Q1 2016 | $728,000 | +145.1% | 7,670 | +139.7% | 0.04% | +140.0% |
| Q4 2015 | $297,000 | +8.8% | 3,200 | 0.0% | 0.02% | +7.1% |
| Q3 2015 | $273,000 | -0.4% | 3,200 | 0.0% | 0.01% | +16.7% |
| Q2 2015 | $274,000 | +0.7% | 3,200 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $272,000 | -12.0% | 3,200 | -11.1% | 0.01% | -14.3% |
| Q4 2014 | $309,000 | +9.2% | 3,600 | -3.5% | 0.01% | +16.7% |
| Q3 2014 | $283,000 | -89.3% | 3,730 | -88.9% | 0.01% | -89.3% |
| Q2 2014 | $2,643,000 | +878.9% | 33,565 | +832.4% | 0.11% | +833.3% |
| Q1 2014 | $270,000 | -16.7% | 3,600 | -14.3% | 0.01% | 0.0% |
| Q4 2013 | $324,000 | +11.3% | 4,200 | 0.0% | 0.01% | +9.1% |
| Q3 2013 | $291,000 | -74.2% | 4,200 | -76.5% | 0.01% | -72.5% |
| Q2 2013 | $1,130,000 | – | 17,850 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |